DelveInsight Blog
Trending:
Bristol-Myers Squibb’s Opdivo & Yervo...
Aug 02, 2022
Bristol-Myers Squibb’s Opdivo and Yervoy Combo Fails in Phase III Trial Bristol-Myers Squibb has reported that their ...
GSK’s RSV Vaccine Clears Phase III Test in...
Jun 14, 2022
GSK Starts Preparations for Regulatory Filings as RSV Vaccine Clears Phase III Test in Adults GSK plans to initiate p...
CG Oncology Teams Up With Merck & BMS...
Jun 07, 2022
FDA Gives Green Signal to First Measles Vaccine in Almost 50 Years GSK announced that the company's vaccine for prote...
Sign Up and Stay Informed
Penetrative insights and rich analysis of Pharma, Biotech and MedTech space.
Editor's Pick
Can denovoSkin Be A Lifesaver for Burn Victims?
Burn is a global public health problem, causing more than 180,000 deaths per year acros...
NexoBrid and its Awaiting US Approval
A Burn takes place when the skin comes into contact with a heat source. Burns can occur...
New Clinical Developments in the Pulmonary Arterial Hypertension Treatment Do...
Pulmonary arterial hypertension is a progressive disease of the lung vascular system, p...
Commercial Roadmap for the Launch: What can Biopharmaceuticals do to Increase...
The Pharma and Biotech Healthcare market has been an ever-changing industry in terms of...
Emerging Market for Organ on a Chip
The organ on a chip is a microfluidic culture device that recapitulates the complicated...
RECENT ARTICLES
-Agonist.png "Toll-like Receptors Agonist")
